Vera Therapeutics, Inc. (VERA) Form 8-K Material Events
Vera Therapeutics, Inc. (VERA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VERA
CIK: 1831828
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerKatie Wechsler
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-17 | 2026-09-15 | 4 Filing | 0001859453-26-000015 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-15 | 8-K | 0001193125-26-391280 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-11 | 4 Filing | 0001861684-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | 4 Filing | 0001859453-26-000014 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001950047-26-009028 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001907884-26-000015 | View SEC Doc Filr Page |
| 4/A | 2026-08-12 | 2026-07-07 | 4/A Filing | 0001859453-26-000013 | View SEC Doc Filr Page |
| 4/A | 2026-08-12 | 2026-06-23 | 4/A Filing | 0001859453-26-000012 | View SEC Doc Filr Page |
| 4/A | 2026-08-12 | 2026-05-12 | 4/A Filing | 0001859453-26-000011 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001193125-26-342380 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-342335 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000554 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 Filing | 0002145711-26-000002 | View SEC Doc Filr Page |
| 3 | 2026-08-05 | 2026-08-03 | 3 Filing | 0002145711-26-000001 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-30 | — | SCHEDULE 13G/A Filing | 0002012383-26-003123 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-07-07 | 4 Filing | 0001859453-26-000010 | View SEC Doc Filr Page |
| 8-K | 2026-07-09 | 2026-07-09 | 8-K | 0001193125-26-299165 | View SEC Doc Filr Page |
| 8-K | 2026-07-07 | 2026-07-07 | 8-K | 0001193125-26-297211 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-23 | 4 Filing | 0001859453-26-000008 | View SEC Doc Filr Page |
| 144 | 2026-06-23 | — | 144 Filing | 0001950047-26-006433 | View SEC Doc Filr Page |
| 8-K | 2026-06-02 | 2026-06-02 | 8-K | 0001193125-26-252475 | View SEC Doc Filr Page |
| 8-K | 2026-05-26 | 2026-05-21 | 8-K | 0001193125-26-239559 | View SEC Doc Filr Page |
| 4 | 2026-05-26 | 2026-05-21 | 4 Filing | 0001662426-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-26 | 2026-05-21 | 4 Filing | 0001778307-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-26 | 2026-05-21 | 4 Filing | 0001184592-26-000002 | View SEC Doc Filr Page |